{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T13:28:30Z","timestamp":1779370110081,"version":"3.53.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2009,3,19]],"date-time":"2009-03-19T00:00:00Z","timestamp":1237420800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s00198-009-0893-2","type":"journal-article","created":{"date-parts":[[2009,3,18]],"date-time":"2009-03-18T07:08:24Z","timestamp":1237360104000},"page":"1895-1902","source":"Crossref","is-referenced-by-count":10,"title":["Risedronate dosing before breakfast compared with dosing later in the day in women with postmenopausal osteoporosis"],"prefix":"10.1007","volume":"20","author":[{"given":"D. L.","family":"Kendler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. D.","family":"Ringe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. -G.","family":"Ste-Marie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Vrijens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. B.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. D.","family":"Delmas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,19]]},"reference":[{"key":"893_CR1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0002-9343(97)00467-1","volume":"102","author":"NH Miller","year":"1997","unstructured":"Miller NH (1997) Compliance with treatment regimens in chronic asymptomatic diseases. Am J Med 102:43\u201349","journal-title":"Am J Med"},{"key":"893_CR2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.maturitas.2004.02.005","volume":"48","author":"JS McCombs","year":"2004","unstructured":"McCombs JS, Thiebaud P, McLaughlin-Miley C et al (2004) Compliance with drug therapies for the treatment and prevention of osteoporosis. Maturitas 48:271\u2013287","journal-title":"Maturitas"},{"key":"893_CR3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","volume":"353","author":"L Osterberg","year":"2005","unstructured":"Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353:487\u2013497","journal-title":"N Engl J Med"},{"key":"893_CR4","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/PL00004152","volume":"7","author":"B Clemmesen","year":"1997","unstructured":"Clemmesen B, Ravn P, Zegels B et al (1997) A 2-year phase II study with 1-year of follow-up of risedronate (NE-58095) in postmenopausal osteoporosis. Osteoporos Int 7:488\u2013495","journal-title":"Osteoporos Int"},{"key":"893_CR5","first-page":"396","volume":"83","author":"L Mortensen","year":"1998","unstructured":"Mortensen L, Charles P, Bekker PJ et al (1998) Risedronate increases bone mass in an early postmenopausal population: two years of treatment plus one year of follow-up. J Clin Endocrinol Metab 83:396\u2013402","journal-title":"J Clin Endocrinol Metab"},{"key":"893_CR6","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","volume":"282","author":"ST Harris","year":"1999","unstructured":"Harris ST, Watts NB, Genant HK et al (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. JAMA 282:1344\u20131352","journal-title":"JAMA"},{"key":"893_CR7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001980050010","volume":"11","author":"JY Reginster","year":"2000","unstructured":"Reginster JY, Minne HW, S\u00f6renson OH, on behalf of the Vertebral Efficacy with Risedronate Therapy (VERT) Study Group et al (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int 11:83\u201391","journal-title":"Osteoporos Int"},{"key":"893_CR8","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1046\/j.1365-2125.1999.00035.x","volume":"48","author":"DY Mitchell","year":"1999","unstructured":"Mitchell DY, Heise MA, Pallone KA et al (1999) The effect of dosing regimen on the pharmacokinetics of risedronate. Br J Clin Pharmacol 48:536\u2013542","journal-title":"Br J Clin Pharmacol"},{"key":"893_CR9","unstructured":"Vrijens B, van de Langerijt L, Watts NB, et al (2003) Electronic monitoring of adherence to therapy in postmenopausal osteoporosis: the IMPACT study. Proceedings of the 30th European Symposium on Calcified Tissues, May 8\u20139"},{"key":"893_CR10","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1210\/jc.2006-1526","volume":"92","author":"PD Delmas","year":"2007","unstructured":"Delmas PD, Vrijens B, Eastell R, on behalf of the Improving Measurements of Persistence on Actonel Treatment (IMPACT) Investigators et al (2007) Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab 92:1296\u20131304","journal-title":"J Clin Endocrinol Metab"},{"key":"893_CR11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00002480-200001000-00006","volume":"46","author":"SJ Phillips","year":"2000","unstructured":"Phillips SJ (2000) FDA reform legislation and its effect on clinical trials. ASAIO J 46:19\u201320","journal-title":"ASAIO J"},{"key":"893_CR12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1385\/JCD:7:3:255","volume":"7","author":"NB Watts","year":"2004","unstructured":"Watts NB, Cooper C, Lindsay R et al (2004) Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk. J Clin Densitom 7:255\u2013261","journal-title":"J Clin Densitom"},{"key":"893_CR13","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1532-5415.2006.00696.x","volume":"54","author":"S Agrawal","year":"2006","unstructured":"Agrawal S, Krueger DC, Engelke JA et al (2006) Between-meal risedronate does not alter bone turnover in nursing home residents. J Am Geriatr Soc 54:790\u2013795","journal-title":"J Am Geriatr Soc"},{"key":"893_CR14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1185\/030079903125002009","volume":"19","author":"D Hosking","year":"2003","unstructured":"Hosking D, Adami S, Felsenberg D et al (2003) Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomised, placebo-controlled study. Curr Med Res Opin 19:383\u2013394","journal-title":"Curr Med Res Opin"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-009-0893-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-009-0893-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-009-0893-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T15:01:03Z","timestamp":1558623663000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-009-0893-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,19]]},"references-count":14,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["893"],"URL":"https:\/\/doi.org\/10.1007\/s00198-009-0893-2","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,19]]}}}